• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受无创通气支持的新型冠状病毒肺炎患者的维生素D情况

Vitamin D in SARS-CoV-2 patients with non-invasive ventilation support.

作者信息

Barassi Alessandra, Pezzilli Raffaele, Mondoni Michele, Rinaldo Rocco F, Davì Matteo, Cozzolino Mario, Melzi D'Eril Gianvico, Centanni Stefano

机构信息

Laboratory of Clinical Chemistry, ASST Santi Paolo e Carlo, San Paolo Hospital, Milan, Italy.

Department of Health Sciences, University of Milan, Milan, Italy.

出版信息

Panminerva Med. 2023 Mar;65(1):23-29. doi: 10.23736/S0031-0808.21.04277-4. Epub 2021 Jan 25.

DOI:10.23736/S0031-0808.21.04277-4
PMID:33494567
Abstract

BACKGROUND

Vitamin D (VitD) deficiency has been reported to be associated with respiratory tract infection. In this work we evaluated the concentration of VitD in COVID-19 patients experiencing acute respiratory infections of different levels of severity excluding those who underwent invasive respiratory support.

METHODS

The levels of serum VitD and C-reactive protein (CRP) were analyzed in 118 consecutive hospitalized COVID-19 patients (74 male, 44 female), confirmed with rRT-PCR. Of these patients with ventilation support 52 (44.1%) received oxygen via nasal cannula, oxygen mask or an oxygen mask with a reservoir, 48 (40.7%) were on a continuous positive airway pressure device (CPAP) and 18 (15,3%) on non-invasive mechanical ventilation (NIMV).

RESULTS

The median values (range) of VitD and of CRP were 15.1 ng/mL (1.3-73.3) and 14.2 mg/L (5.0-151.2), respectively. A negative correlation from VitD levels and those of CRP (correlation coefficient: 0.259: P=0.005) was observed. VitD levels in O2 support patients were significantly higher than in both CPAP and NIMV patients. No statistical differences were found for CRP levels (P=0.834) among the three type of oxygen support. Fewer patients with O2 support had VitD <30 ng/mL and <20 ng/mL than CPAP and NIMV patients. There were no relationships between VitD and the three classes of IgM (P=0.419) and of IgG (P=0.862) SARS-CoV-2 antibodies values. The behavior was the same for CRP.

CONCLUSIONS

Our study shows that a significant proportion of COVID-19 patients have a VitD deficiency and that this condition is more frequent in CPAP and in NIMV patients.

摘要

背景

据报道,维生素D(VitD)缺乏与呼吸道感染有关。在本研究中,我们评估了排除接受有创呼吸支持的患者后,不同严重程度急性呼吸道感染的新型冠状病毒肺炎(COVID-19)患者的VitD浓度。

方法

对118例经逆转录聚合酶链反应(rRT-PCR)确诊的连续住院COVID-19患者(74例男性,44例女性)的血清VitD和C反应蛋白(CRP)水平进行分析。在这些接受通气支持的患者中,52例(44.1%)通过鼻导管、氧气面罩或带储氧袋的氧气面罩吸氧,48例(40.7%)使用持续气道正压通气装置(CPAP),18例(15.3%)接受无创机械通气(NIMV)。

结果

VitD和CRP的中位数(范围)分别为15.1 ng/mL(1.3 - 73.3)和14.2 mg/L(5.0 - 151.2)。观察到VitD水平与CRP水平呈负相关(相关系数:0.259;P = 0.005)。接受氧气支持的患者的VitD水平显著高于接受CPAP和NIMV的患者。三种氧气支持类型之间的CRP水平无统计学差异(P = 0.834)。与接受CPAP和NIMV的患者相比,接受氧气支持的患者中VitD<30 ng/mL和<20 ng/mL的患者较少。VitD与三类新型冠状病毒2(SARS-CoV-2)IgM抗体值(P = 0.419)和IgG抗体值(P = 0.862)之间无相关性。CRP的情况相同。

结论

我们的研究表明,相当一部分COVID-19患者存在VitD缺乏,且这种情况在接受CPAP和NIMV的患者中更常见。

相似文献

1
Vitamin D in SARS-CoV-2 patients with non-invasive ventilation support.接受无创通气支持的新型冠状病毒肺炎患者的维生素D情况
Panminerva Med. 2023 Mar;65(1):23-29. doi: 10.23736/S0031-0808.21.04277-4. Epub 2021 Jan 25.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
No significant association between vitamin D and COVID-19: A retrospective study from a northern Italian hospital.维生素 D 与 COVID-19 之间无显著关联:来自意大利北部一家医院的回顾性研究。
Int J Vitam Nutr Res. 2021 Jun;91(3-4):200-203. doi: 10.1024/0300-9831/a000687. Epub 2020 Nov 2.
4
Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin D.维生素 D 介导的 COVID-19 和骨质疏松症的共同机制和串扰。
Sci Rep. 2022 Oct 28;12(1):18147. doi: 10.1038/s41598-022-23143-7.
5
Early predictors for mechanical ventilation in COVID-19 patients.新型冠状病毒肺炎患者机械通气的早期预测指标。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963017. doi: 10.1177/1753466620963017.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation.维生素 D 与住院老年患者 COVID-19 严重程度:院前补充维生素 D 的潜在益处。
Nutrients. 2022 Apr 14;14(8):1641. doi: 10.3390/nu14081641.
8
Vitamin D and COVID-19: It is time to act.维生素 D 与 COVID-19:是采取行动的时候了。
Int J Clin Pract. 2021 Mar;75(3):e13748. doi: 10.1111/ijcp.13748. Epub 2020 Oct 27.
9
Characteristics, outcomes and global trends of respiratory support in patients hospitalized with COVID-19 pneumonia: a scoping review.COVID-19 肺炎住院患者呼吸支持的特征、结局和全球趋势:范围综述。
Minerva Anestesiol. 2021 Aug;87(8):915-926. doi: 10.23736/S0375-9393.21.15486-0. Epub 2021 May 26.
10
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.高流量鼻导管给氧治疗严重新型冠状病毒肺炎所致呼吸衰竭:一项真实世界观察性研究。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016.

引用本文的文献

1
Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.维生素 D:在 COVID-19 免疫中的关键角色,以及从大流行中吸取的对抗免疫逃避变异体的经验教训。
Inflammopharmacology. 2024 Dec;32(6):3631-3652. doi: 10.1007/s10787-024-01578-w. Epub 2024 Oct 16.
2
Is the vitamin D status of patients with COVID-19 associated with reduced mortality? A systematic review and meta-analysis.COVID-19 患者的维生素 D 状况是否与降低死亡率相关?系统评价和荟萃分析。
Arch Endocrinol Metab. 2023 Mar 10;67(2):276-288. doi: 10.20945/2359-3997000000588.
3
Machine learning approach for automated predicting of COVID-19 severity based on clinical and paraclinical characteristics: Serum levels of zinc, calcium, and vitamin D.
基于临床和检验特征的机器学习方法对 COVID-19 严重程度的自动预测:血清锌、钙和维生素 D 水平。
Clin Nutr ESPEN. 2022 Oct;51:404-411. doi: 10.1016/j.clnesp.2022.07.011. Epub 2022 Jul 31.
4
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis.维生素 D 与 SARS-CoV2 感染、严重程度和死亡率:系统评价和荟萃分析。
PLoS One. 2022 Jul 6;17(7):e0268396. doi: 10.1371/journal.pone.0268396. eCollection 2022.
5
Hallmarks of Severe COVID-19 Pathogenesis: Between Viral and Host Factors.严重 COVID-19 发病机制的特征:病毒和宿主因素之间。
Front Immunol. 2022 Jun 10;13:912336. doi: 10.3389/fimmu.2022.912336. eCollection 2022.
6
Calcifediol for Use in Treatment of Respiratory Disease.钙化醇在治疗呼吸疾病中的应用。
Nutrients. 2022 Jun 13;14(12):2447. doi: 10.3390/nu14122447.
7
Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation.维生素 D 与住院老年患者 COVID-19 严重程度:院前补充维生素 D 的潜在益处。
Nutrients. 2022 Apr 14;14(8):1641. doi: 10.3390/nu14081641.
8
Relationship of anti-SARS-CoV-2 IgG antibodies with Vitamin D and inflammatory markers in COVID-19 patients.新型冠状病毒 IgG 抗体与 COVID-19 患者维生素 D 和炎症标志物的关系。
Sci Rep. 2022 Apr 5;12(1):5699. doi: 10.1038/s41598-022-09785-7.
9
Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients.维生素 D、维生素 D 结合蛋白、游离维生素 D 与住院患者 COVID-19 死亡率的关系。
Am J Clin Nutr. 2022 May 1;115(5):1367-1377. doi: 10.1093/ajcn/nqac027.
10
The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2.维生素 D 和皮质类固醇的相互作用:对 26508 名 SARS-CoV-2 检测呈阳性的退伍军人的死亡率分析。
Int J Environ Res Public Health. 2021 Dec 31;19(1):447. doi: 10.3390/ijerph19010447.